Company Filing History:
1 out of 45 
1 out of 37 
1 out of 5 
Years Active: 1993-2013
Title: Kazuo Takahama: Innovator in Pharmaceutical Composition
Introduction
Kazuo Takahama is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating cough and central nervous system disorders. With a total of 3 patents to his name, Takahama's work reflects a commitment to advancing medical science.
Latest Patents
Takahama's latest patents include a groundbreaking pharmaceutical composition effective for suppressing cough. This invention utilizes activated Factor XI as an antitussive for coughs caused by stimulation at the tracheal bifurcation, such as chronic cough. The composition comprises a polypeptide chain as an active ingredient, which can include variations of the amino acid sequence of activated Factor XI.
Another significant patent involves morphan derivatives or their salts, which are medicinal compositions that regulate the activation of glycine receptors. These compositions are designed to potentiate or inhibit glycine receptor activation, making them valuable as drugs for the central nervous system. The novel 1- and/or 2-substituted morphan derivatives represent a promising area of research in pharmacology.
Career Highlights
Throughout his career, Takahama has worked with reputable organizations, including Mect Corporation and the Chemo-Sero-Therapeutic Research Institute. His experience in these companies has allowed him to develop innovative solutions in the pharmaceutical industry.
Collaborations
Takahama has collaborated with esteemed colleagues such as Takeshi Miyata and Hirofumi Kai. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kazuo Takahama's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare through scientific research. His patents reflect a deep understanding of complex biological mechanisms and a commitment to developing effective treatments.